NCI cancer research at WVU doubles in two years

Mary Babb Randolph Cancer Center also names deputy director

MORGANTOWN, W.Va. – Since 2007 scientists at West Virginia University have more than doubled research dollars that flow from the National Cancer Institute (NCI) to WVU, said Scot Remick, M.D., director of the Mary Babb Randolph Cancer Center at WVU.

The Cancer Center’s scientists are working on projects representing almost $2 million in NCI funding, he said during the Cancer Center’s annual retreat earlier in August. Overall research grant funding for the Cancer Center is $8 million.

Dr. Remick also announced that the Cancer Center now has a deputy director: Laura Gibson, Ph.D., who in March was named the first Alexander B. Osborn Distinguished Professor in Hematological Malignancies Research.

“She has extraordinary talent,” Remick said. “This is a tremendous opportunity for the Cancer Center to grow. She will help in recruiting more physician scientists in part because of her enthusiasm for research and her attention to nurturing of the next generation of cancer researchers.”

Laura Gibson, Ph.D.

Gibson’s research includes a five-year, $1.47 million NCI grant to study stem cells to find better ways to treat acute lymphoblastic leukemia (ALL), the most common leukemia in children. 

“I love the energy in the Cancer Center and the goals we have set,” Gibson said. “I’m excited about forming outside partnerships and working more closely with fellow scientists to study problems such as the link between obesity and cancer.”

Remick reiterated the importance of research on cancer in a state with the 4th highest mortality rate from cancer in the nation. West Virginia also has high rates of obesity and tobacco use, both known risk factors for various kinds of cancer.



For more information:
Andrea Brunais, HSC News Service, 304-293-7087
AB: 08-7-09

Return To News Releases